Linglin Huang

Linglin Huang

Auto-generated profile, based on publicly available information

Linglin Huang

Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2021 in Cell
Verified
Journal Article
Closed access
ASAlexandra Schnell
Alexandra Schnell
LHLinglin Huang
Linglin Huang
MSMeromit Singer
Meromit Singer
ASAnvita Singaraju
Anvita Singaraju
RBRocky M. Barilla
Rocky M. Barilla
VKVijay K. Kuchroo
Vijay K. Kuchroo

2 March 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KPKristen E. Pauken
Kristen E. Pauken
OSOsmaan Shahid
Osmaan Shahid
KLKaitlyn A. Lagattuta
Kaitlyn A. Lagattuta
KMKelly Mahuron
Kelly Mahuron
JLJacob Luber
Jacob Luber
MSMeromit Singer
Meromit Singer
The ability to monitor anti-tumor CD8+ T cell responses in the blood has tremendous therapeutic potential. Here, we used paired single-cell RNA and TCR sequencing to detect and characterize “tumor-matching” (TM) CD8+ T cells in the blood of mice with MC38 tumors or melanoma patients using the TCR as a molecular barcode. TM cells showed increased activation compared with nonmatching T cells in blood and were less exhausted than matching cells in tumors. Importantly, PD-1, which has been used to identify putative circulating anti-tumor CD8+ T cells, showed poor sensitivity for identifying TM cells. By leveraging the transcriptome, we identified candidate cell surface markers for TM cells in mice and patients and validated NKG2D, CD39, and CX3CR1 in mice. These data show that the TCR can be used to identify tumor-relevant cells for characterization, reveal unique transcriptional properties of TM cells, and develop marker panels for tracking and analysis of these cells.

1 October 2020 in Journal of the American Academy of Dermatology
Verified
Journal Article
Open access
NBNicole L. Bolick
Nicole L. Bolick
LHLinglin Huang
Linglin Huang
AMArash Mostaghimi
Arash Mostaghimi
RHRebecca I. Hartman
Rebecca I. Hartman

1 December 2020 in Preventive Medicine Reports
Verified
Journal Article
Open access
NBNicole L. Bolick
Nicole L. Bolick
LHLinglin Huang
Linglin Huang
AGAlan C. Geller
Alan C. Geller
To determine if geographical differences exist in practice of sun protective behaviors across the United States, we performed a retrospective, cross-sectional analysis of data from the Health Information National Trends Survey 4 Cycle 3. Self-reported sun protective behaviors and demographic information were collected for individuals from nine regions across the United States in 2013. Regions followed United States census divisions, including New England, Middle Atlantic, East North Central, West North Central, South Atlantic, East South Central, West South Central, Mountain, and Pacific. Study participants included 3,185 people from nine census regions. Sun protection was uncommonly practiced in the United States. The use of sunscreen in the West North Central region was the lowest sun protective practice. Long pants were more commonly worn in the West South Central and the Pacific. Sun protective behavior rates are low for all geographic locations across the United States. Future public health campaigns should place less emphasis on geographical influences of sun protective behaviors and focus more so on comprehensive, nationwide sun prevention campaigns.

24 April 2026 in Science Immunology
Verified
Journal Article
Closed access
AHAllen W. Ho
Allen W. Ho
LHLinglin Huang
Linglin Huang
SSSumiti Sandhu
Sumiti Sandhu
SXSheng Xiao
Sheng Xiao
MSMelissa Sgodzai
Melissa Sgodzai
VKVijay K. Kuchroo
Vijay K. Kuchroo
T helper 17 (T H 17) cells are thought to play an important role in the pathogenesis of many autoimmune disorders, including multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). However, recent studies have suggested that interleukin-17 (IL-17) may be dispensable for the induction of EAE. Here, we use an adoptive transfer model of EAE to demonstrate that an adaptive cellular source of IL-17 is absolutely required for the induction of EAE disease. We further show that B cells can regulate the transfer of EAE disease in this context. Transcriptional profiling of T H 17 cells in our model suggests that loss of IL-17A/F in T cells results in a lack of an IL-23 receptor (IL-23R)–driven signaling signature. Our data demonstrate the critical importance of an adaptive immune cellular source of IL-17A and IL-17F to mediate EAE and that IL-17 signaling is required for IL-23–mediated T H 17 cell pathogenicity.